Skip to main content
Erschienen in: Osteoporosis International 7/2010

01.07.2010 | Original Article

Independent from muscle power and balance performance, a creatinine clearance below 65 ml/min is a significant and independent risk factor for falls and fall-related fractures in elderly men and women diagnosed with osteoporosis

verfasst von: L. Dukas, E. Schacht, M. Runge

Erschienen in: Osteoporosis International | Ausgabe 7/2010

Einloggen, um Zugang zu erhalten

Abstract

Summary

We assessed in a cross-sectional study in elderly men and women with osteoporosis, the association between the creatinine clearance (CrCl) and the performance in different balance and muscle power and function tests and found that a decreasing creatinine clearance was significantly associated with lower balance and muscle power.

Introduction

To determine if a creatinine clearance of <65 ml/min is significantly associated with decreasing muscle power and balance and an increased risk for falls and fractures.

Methods

We assessed in a cross-sectional-study in 1781 German osteoporotic patients, the association between the CrCl, the physical performance, and the number of falls and fractures.

Results

Controlling for age, gender, BMI, and osteoporosis treatment (fracture analysis only), a decreasing CrCl was associated with lower physical performance in the timed-up-and-go test (corr −0.2337, P < 0.0001), chair-rising test (corr −0.1706, P < 0.001), and tandem-stand test (corr 0.2193, P < 0.0001), and a CrCl of <65 ml/min was associated with a significantly higher risk for falls (47.7% vs. 36.2%, P = 0.0008) and fall-related fractures (33.1% vs. 22.9%, P = 0.0003) compared with a CrCl of ≥65 ml/min.

Conclusions

In this study, we found a significant gender-independent correlation between decreasing CrCl and lower performance in balance and muscle power tests. Reduced muscle power and balance may therefore be involved in the low creatinine clearance associated increased risk for falls and fall-related fractures. Furthermore, we found that a CrCl <65 ml/min., independent from the performance in muscle power, muscle function, and balance tests, is a significant risk factor for falls and fractures.
Literatur
1.
Zurück zum Zitat Tinetti ME, Inouye SK, Gill TM et al (1995) Shared risk factors for falls, incontinence, and functional dependence. Unifying the approach to geriatric syndromes. JAMA 273(17):1348–1353CrossRefPubMed Tinetti ME, Inouye SK, Gill TM et al (1995) Shared risk factors for falls, incontinence, and functional dependence. Unifying the approach to geriatric syndromes. JAMA 273(17):1348–1353CrossRefPubMed
2.
Zurück zum Zitat Bischoff HA, Stähelin HB, Urscheler N et al (1999) Muscle strength in the elderly: its relation to vitamin D metabolites. Arch Phys Med Rehabil 80(1):54–58CrossRefPubMed Bischoff HA, Stähelin HB, Urscheler N et al (1999) Muscle strength in the elderly: its relation to vitamin D metabolites. Arch Phys Med Rehabil 80(1):54–58CrossRefPubMed
3.
Zurück zum Zitat Pfeifer M, Begerow B, Minne HW et al (2000) Effects of a short-term vitamin D and calcium supplementation on body sway and secondary hyperparathyroidism in elderly women. J Bone Miner Res 15(6):1113–1118CrossRefPubMed Pfeifer M, Begerow B, Minne HW et al (2000) Effects of a short-term vitamin D and calcium supplementation on body sway and secondary hyperparathyroidism in elderly women. J Bone Miner Res 15(6):1113–1118CrossRefPubMed
4.
Zurück zum Zitat Dukas L, Staehelin HB, Schacht E, Bischoff HA (2005) Better functional mobility in community-dwelling elderly is related to d-hormone serum levels and a to a daily calcium intake. Nutr Health Aging 9(5):347–351 Dukas L, Staehelin HB, Schacht E, Bischoff HA (2005) Better functional mobility in community-dwelling elderly is related to d-hormone serum levels and a to a daily calcium intake. Nutr Health Aging 9(5):347–351
5.
Zurück zum Zitat Bischoff HA, Stähelin HB, Dick W et al (2003) Effects of vitamin D and calcium supplementation on falls: a randomized controlled trial. J Bone Miner Res 18:343–351CrossRefPubMed Bischoff HA, Stähelin HB, Dick W et al (2003) Effects of vitamin D and calcium supplementation on falls: a randomized controlled trial. J Bone Miner Res 18:343–351CrossRefPubMed
6.
Zurück zum Zitat Gallagher JC (2004) The effects of calcitriol on falls and fractures and physical performance tests. J Steroid Biochem Mol Biol 89–90:497–501CrossRefPubMed Gallagher JC (2004) The effects of calcitriol on falls and fractures and physical performance tests. J Steroid Biochem Mol Biol 89–90:497–501CrossRefPubMed
7.
Zurück zum Zitat Dukas L, Bischoff HA, Lindpaintner LS, Schacht E, Birkner-Binder D, Damm T, Thalmann B, Stähelin HB (2004) Alfacalcidol reduces the number of fallers in a community-dwelling elderly population with a minimum calcium intake of 500 mg daily. J Am Geriatr Soc 52:1–7CrossRef Dukas L, Bischoff HA, Lindpaintner LS, Schacht E, Birkner-Binder D, Damm T, Thalmann B, Stähelin HB (2004) Alfacalcidol reduces the number of fallers in a community-dwelling elderly population with a minimum calcium intake of 500 mg daily. J Am Geriatr Soc 52:1–7CrossRef
8.
Zurück zum Zitat Faulkner KA, Cauley JA, Zmuda JM, Landsittel DP, Newman AB, Studenski SA, Redfern MS, Ensrud KE, Fink HA, Lane NE, Nevitt MC (2006) Higher 1,25-dihydroxyvitamin D3 concentrations associated with lower fall rates in older community-dwelling women. Osteoporos Int 17(9):1318–1328CrossRefPubMed Faulkner KA, Cauley JA, Zmuda JM, Landsittel DP, Newman AB, Studenski SA, Redfern MS, Ensrud KE, Fink HA, Lane NE, Nevitt MC (2006) Higher 1,25-dihydroxyvitamin D3 concentrations associated with lower fall rates in older community-dwelling women. Osteoporos Int 17(9):1318–1328CrossRefPubMed
9.
10.
Zurück zum Zitat Sorensen OH, Lund BI, Saltin B et al (1979) Myopathy in bone loss of aging: improvement by treatment with 1 alpha-hydroxycholecalciferol and calcium. Clin Sci 56(2):157–161PubMed Sorensen OH, Lund BI, Saltin B et al (1979) Myopathy in bone loss of aging: improvement by treatment with 1 alpha-hydroxycholecalciferol and calcium. Clin Sci 56(2):157–161PubMed
11.
Zurück zum Zitat Endo I, Inoue D, Mitsui T, Umaki Y, Akaike M, Yoshizawa T, Kato S, Matsumoto T (2003) Deletion of vitamin D receptor gene in mice results in abnormal skeletal muscle development with deregulated expression of myoregulatory transcription factors. Endocrinology 144(12):5138–5144CrossRefPubMed Endo I, Inoue D, Mitsui T, Umaki Y, Akaike M, Yoshizawa T, Kato S, Matsumoto T (2003) Deletion of vitamin D receptor gene in mice results in abnormal skeletal muscle development with deregulated expression of myoregulatory transcription factors. Endocrinology 144(12):5138–5144CrossRefPubMed
12.
Zurück zum Zitat Dukas L, Schacht E, Stahelin HB (2005) In elderly men and women treated for osteoporosis a low creatinine clearance of <65 ml/min is a risk factor for falls and fractures. Osteoporos Int 16(12):1683–1690CrossRefPubMed Dukas L, Schacht E, Stahelin HB (2005) In elderly men and women treated for osteoporosis a low creatinine clearance of <65 ml/min is a risk factor for falls and fractures. Osteoporos Int 16(12):1683–1690CrossRefPubMed
13.
Zurück zum Zitat Dukas LC, Schacht E, Mazor Z, Stahelin HB (2005) A new significant and independent risk factor for falls in elderly men and women: a low creatinine clearance of less than 65 ml/min. Osteoporos Int 16(3):332–338CrossRefPubMed Dukas LC, Schacht E, Mazor Z, Stahelin HB (2005) A new significant and independent risk factor for falls in elderly men and women: a low creatinine clearance of less than 65 ml/min. Osteoporos Int 16(3):332–338CrossRefPubMed
14.
Zurück zum Zitat Dukas L, Schacht E, Mazor Z, Stahelin HB (2005) Treatment with alfacalcidol in elderly people significantly decreases the high risk of falls associated with a low creatinine clearance of <65 ml/min. Osteoporos Int 16(2):198–203CrossRefPubMed Dukas L, Schacht E, Mazor Z, Stahelin HB (2005) Treatment with alfacalcidol in elderly people significantly decreases the high risk of falls associated with a low creatinine clearance of <65 ml/min. Osteoporos Int 16(2):198–203CrossRefPubMed
15.
Zurück zum Zitat Gallagher JC, Rapuri PB, Smith LM (2007) An age related decrease in creatinine clearance is associated with an increase in number of falls in untreated women but not in women receiving calcitriol. J Clin Endocrinol Metab 92:51–58CrossRefPubMed Gallagher JC, Rapuri PB, Smith LM (2007) An age related decrease in creatinine clearance is associated with an increase in number of falls in untreated women but not in women receiving calcitriol. J Clin Endocrinol Metab 92:51–58CrossRefPubMed
16.
Zurück zum Zitat Ensrud KE, Lui L-Y, Taylor BC, Ishani A, Shlipak MG, Stone KL, Cauley JA, Jamal SA, Antoniucci DM, Cummings SR, for the Study of Osteoporotic Fractures Research Group (2007) Renal function and risk of hip and vertebral fractures in older women. Arch Intern Med 167:133–139CrossRefPubMed Ensrud KE, Lui L-Y, Taylor BC, Ishani A, Shlipak MG, Stone KL, Cauley JA, Jamal SA, Antoniucci DM, Cummings SR, for the Study of Osteoporotic Fractures Research Group (2007) Renal function and risk of hip and vertebral fractures in older women. Arch Intern Med 167:133–139CrossRefPubMed
17.
Zurück zum Zitat Cockcroft DW, Gault MH (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16(1):31–41CrossRefPubMed Cockcroft DW, Gault MH (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16(1):31–41CrossRefPubMed
18.
Zurück zum Zitat Podsialdo D, Richardson S (1991) The timed "Up & Go": a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc 39(2):142–148 Podsialdo D, Richardson S (1991) The timed "Up & Go": a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc 39(2):142–148
19.
Zurück zum Zitat Mathias S, Nayak US, Isaacs B (1986) Balance in elderly patients: the "get-up and go" test. Arch Phys Med Rehabil 67(6):387–389PubMed Mathias S, Nayak US, Isaacs B (1986) Balance in elderly patients: the "get-up and go" test. Arch Phys Med Rehabil 67(6):387–389PubMed
20.
Zurück zum Zitat Zhu K, Devine A, Prince RL (2008) Timed Up and Go Test and BMD as predictors of fractures: a 10-year longitudinal study. J Bone Min Res 23:s119 Zhu K, Devine A, Prince RL (2008) Timed Up and Go Test and BMD as predictors of fractures: a 10-year longitudinal study. J Bone Min Res 23:s119
21.
Zurück zum Zitat Guralnik JM, Ferrucci L, Simonsick EM, Salive ME, Wallace RB (1995) Lower-extremity function in persons over the age of 70 years as a predictor of subsequent disability. N Eng J Med 332:556–561CrossRef Guralnik JM, Ferrucci L, Simonsick EM, Salive ME, Wallace RB (1995) Lower-extremity function in persons over the age of 70 years as a predictor of subsequent disability. N Eng J Med 332:556–561CrossRef
22.
Zurück zum Zitat Gill TM, Williams CS, Tinetti ME (1995) Assessing risk for the onset of functional dependence among older adults: the role of physical performance. J Am Geriatr Soc 43:603–609PubMed Gill TM, Williams CS, Tinetti ME (1995) Assessing risk for the onset of functional dependence among older adults: the role of physical performance. J Am Geriatr Soc 43:603–609PubMed
23.
Zurück zum Zitat Runge M, Rehfeld G, Resnicek E (2000) Balance training and exercise in geriatric patients. J Musculoskel Neuronal Interact 1:54–58 Runge M, Rehfeld G, Resnicek E (2000) Balance training and exercise in geriatric patients. J Musculoskel Neuronal Interact 1:54–58
24.
Zurück zum Zitat Winer BJ (1971) Statistical principles in experimental design, 2nd edn. McGraw Hill, New York, p 514 Winer BJ (1971) Statistical principles in experimental design, 2nd edn. McGraw Hill, New York, p 514
25.
Zurück zum Zitat Skeleton DA, Greig CA, Davies JM (1994) Strength, power and related functional ability of healthy people aged 65–89 years. Age Ageing 23:371–377CrossRef Skeleton DA, Greig CA, Davies JM (1994) Strength, power and related functional ability of healthy people aged 65–89 years. Age Ageing 23:371–377CrossRef
26.
Zurück zum Zitat Danneskiold-Samsǿe B, Kofod V, Munter J (1984) Muscle strength and functional capacity in 78–81 year old men and women. Eur J Appl Physiol 52:310–314CrossRef Danneskiold-Samsǿe B, Kofod V, Munter J (1984) Muscle strength and functional capacity in 78–81 year old men and women. Eur J Appl Physiol 52:310–314CrossRef
27.
Zurück zum Zitat McMurdo ME (1997) Physical activity and health in old age. Scott Med J 42(5):154–155PubMed McMurdo ME (1997) Physical activity and health in old age. Scott Med J 42(5):154–155PubMed
28.
Zurück zum Zitat Rejeski WJ, Mihalko SL (2001) Physical activity and quality of life in older adults. J Gerontol A Biol Sci Med Sci 56:23–35 Spec No 2(2)PubMed Rejeski WJ, Mihalko SL (2001) Physical activity and quality of life in older adults. J Gerontol A Biol Sci Med Sci 56:23–35 Spec No 2(2)PubMed
29.
Zurück zum Zitat Lee MS, Tanaka K (1997) Significance of health fitness appraisal in an aging society. Appl Human Sci 16(4):123–131CrossRefPubMed Lee MS, Tanaka K (1997) Significance of health fitness appraisal in an aging society. Appl Human Sci 16(4):123–131CrossRefPubMed
30.
Zurück zum Zitat Schacht E (1999) Rationale for treatment of involutional osteoporosis in women and for prevention and treatment of corticosteroid-induced osteoporosis with alfacalcidol. Calcif Tissue Int 65:317–327CrossRefPubMed Schacht E (1999) Rationale for treatment of involutional osteoporosis in women and for prevention and treatment of corticosteroid-induced osteoporosis with alfacalcidol. Calcif Tissue Int 65:317–327CrossRefPubMed
31.
Zurück zum Zitat Lau KHW, Baylink DJ (1999) Vitamin D therapy of osteoporosis: plain vitamin D therapy versus active vitamin D analog (d-hormone) therapy. Calcif Tissue Int 65:295–306CrossRefPubMed Lau KHW, Baylink DJ (1999) Vitamin D therapy of osteoporosis: plain vitamin D therapy versus active vitamin D analog (d-hormone) therapy. Calcif Tissue Int 65:295–306CrossRefPubMed
32.
Zurück zum Zitat Richy F, Deroisy R, Lecart M-P, Hanssens L, Mawet A, Reginster J-Y (2005) D-hormone analog alfacalcidol: an update on its role in post-menopausal osteoporosis and rheumatoid arthritis management. Aging Clin Exp Res 17:133–142PubMed Richy F, Deroisy R, Lecart M-P, Hanssens L, Mawet A, Reginster J-Y (2005) D-hormone analog alfacalcidol: an update on its role in post-menopausal osteoporosis and rheumatoid arthritis management. Aging Clin Exp Res 17:133–142PubMed
33.
Zurück zum Zitat Schacht E, Richy F, Reginster J-Y (2005) The therapeutic effects of alfacalcidol on bone strength, muscle metabolism and prevention of falls and fractures. J Musculoskelet Neuronal Interact 5:273–284PubMed Schacht E, Richy F, Reginster J-Y (2005) The therapeutic effects of alfacalcidol on bone strength, muscle metabolism and prevention of falls and fractures. J Musculoskelet Neuronal Interact 5:273–284PubMed
34.
Zurück zum Zitat Tinetti ME, Williams CS (1998) The effect of falls and fall injuries on functioning in community-dwelling older persons. J Gerontol A Biol Sci Med Sci 53(2):M112–M119PubMed Tinetti ME, Williams CS (1998) The effect of falls and fall injuries on functioning in community-dwelling older persons. J Gerontol A Biol Sci Med Sci 53(2):M112–M119PubMed
35.
Zurück zum Zitat Stein MS, Wark JD, Scherer SC, Walton SL, Chick P, Di Carlantonio M, Zajac JD, Flicker L (1999) Falls related to vitamin D and parathyroid hormone in Australian nursing home and hostel. J Am Ger Soc 47:1195–1201 Stein MS, Wark JD, Scherer SC, Walton SL, Chick P, Di Carlantonio M, Zajac JD, Flicker L (1999) Falls related to vitamin D and parathyroid hormone in Australian nursing home and hostel. J Am Ger Soc 47:1195–1201
36.
Zurück zum Zitat Klawansky S, Komaroff E, Cavanaugh PF, Mitchell DY, Gordon MJ, Connelly JE, Ross SD (2003) The relationship between age, renal function and bone mineral density in the US population. Osteoporos Int 14:570–576CrossRefPubMed Klawansky S, Komaroff E, Cavanaugh PF, Mitchell DY, Gordon MJ, Connelly JE, Ross SD (2003) The relationship between age, renal function and bone mineral density in the US population. Osteoporos Int 14:570–576CrossRefPubMed
37.
Zurück zum Zitat Jassal SK, von Muhlen D, Barrett-Connor E (2007) Measures of renal function, BMD, bone loss, and osteoporotic fracture in older adults: the Rancho Bernardo study. J Bone Miner Res 22:203–210CrossRefPubMed Jassal SK, von Muhlen D, Barrett-Connor E (2007) Measures of renal function, BMD, bone loss, and osteoporotic fracture in older adults: the Rancho Bernardo study. J Bone Miner Res 22:203–210CrossRefPubMed
38.
Zurück zum Zitat Trombetti A, Stoermann-Chopard C, Ferrari S, Saudan P, Chevalley T, Binet I, Uebelhart B, Rizzoli R, Martin PY (2003) Prävention von Knochenkomplikationen bei Patienten mit chronischer Niereninsuffizienz (1.Teil). Swiss Med Forum 11:260–266 Trombetti A, Stoermann-Chopard C, Ferrari S, Saudan P, Chevalley T, Binet I, Uebelhart B, Rizzoli R, Martin PY (2003) Prävention von Knochenkomplikationen bei Patienten mit chronischer Niereninsuffizienz (1.Teil). Swiss Med Forum 11:260–266
39.
Zurück zum Zitat Slovik DM, Adams JS, Neer RM et al (1981) Deficient production of 1,25-dihydroxyvitamin D in elderly osteoporotic patients. N Engl J Med 305:372–374PubMedCrossRef Slovik DM, Adams JS, Neer RM et al (1981) Deficient production of 1,25-dihydroxyvitamin D in elderly osteoporotic patients. N Engl J Med 305:372–374PubMedCrossRef
40.
Zurück zum Zitat Oelzner P, Muller A, Deschner F, Huller M, Abendroth K, Hein G et al (1998) Relationship between disease activity and serum levels of vitamin D metabolites and PTH in rheumatoid arthritis. Calcif Tissue Int 62:193–198CrossRefPubMed Oelzner P, Muller A, Deschner F, Huller M, Abendroth K, Hein G et al (1998) Relationship between disease activity and serum levels of vitamin D metabolites and PTH in rheumatoid arthritis. Calcif Tissue Int 62:193–198CrossRefPubMed
41.
Zurück zum Zitat Epstein S, Bryce G, Hinman JW et al (1986) The influence of age on bone mineral regulating hormones. Bone 7:421–425CrossRefPubMed Epstein S, Bryce G, Hinman JW et al (1986) The influence of age on bone mineral regulating hormones. Bone 7:421–425CrossRefPubMed
42.
Zurück zum Zitat Tsai KS, Heath H III, Kumar R et al (1984) Impaired vitamin D metabolism with aging in women: possible role in pathogenesis of senile osteoporosis. J Clin Invest 73:1668–1672CrossRefPubMed Tsai KS, Heath H III, Kumar R et al (1984) Impaired vitamin D metabolism with aging in women: possible role in pathogenesis of senile osteoporosis. J Clin Invest 73:1668–1672CrossRefPubMed
43.
Zurück zum Zitat Dukas L, Bischoff HA, Schacht E et al (2002) Normal 25(OH) vitamin D serum levels do not exclude d-hormone deficiency in community-dwelling elderly. Osteoporos Int 13(1):S35 Dukas L, Bischoff HA, Schacht E et al (2002) Normal 25(OH) vitamin D serum levels do not exclude d-hormone deficiency in community-dwelling elderly. Osteoporos Int 13(1):S35
44.
Zurück zum Zitat Peacock M, Heyburn P (1977) Effect of vitamin D3 metabolites on proximal muscle weakness. Calcif Tiss Res 24(Suppl):R20–R23 Peacock M, Heyburn P (1977) Effect of vitamin D3 metabolites on proximal muscle weakness. Calcif Tiss Res 24(Suppl):R20–R23
45.
Zurück zum Zitat Verhaar HJJ, Samson MM, Jansen PAF et al (2000) Muscle strength, functional mobility and vitamin D in older women. Aging Clin Exp Res 12:455–460 Verhaar HJJ, Samson MM, Jansen PAF et al (2000) Muscle strength, functional mobility and vitamin D in older women. Aging Clin Exp Res 12:455–460
46.
Zurück zum Zitat Dhesi JK, Bearne LM, Monitz C, Hurley MV, Jackson SHD, Swift CG, Allain TJ (2002) Neuromuscular and psychomotor function in elderly subjects who fall and the relationship with vitamin D status. J Bone Miner Res 17:891–897CrossRefPubMed Dhesi JK, Bearne LM, Monitz C, Hurley MV, Jackson SHD, Swift CG, Allain TJ (2002) Neuromuscular and psychomotor function in elderly subjects who fall and the relationship with vitamin D status. J Bone Miner Res 17:891–897CrossRefPubMed
47.
Zurück zum Zitat Koike T, Okawa T, Wada M, Kita T, Takaoka K (2003) Effects of a long-term alfacalcidol or calcitonin administration on body sway in Japanese elderly women. J Bone Miner Res 18(S2)):S168 Koike T, Okawa T, Wada M, Kita T, Takaoka K (2003) Effects of a long-term alfacalcidol or calcitonin administration on body sway in Japanese elderly women. J Bone Miner Res 18(S2)):S168
48.
Zurück zum Zitat Gryfe CI, Amies A, Ashley MJ (1997) A longitudinal study of falls in an elderly population: incidence and morbidity. Age Aeing 6(4):201–210CrossRef Gryfe CI, Amies A, Ashley MJ (1997) A longitudinal study of falls in an elderly population: incidence and morbidity. Age Aeing 6(4):201–210CrossRef
49.
Zurück zum Zitat Liu S, Tang W, Zhou J et al (2006) Fibroblast growth factor 23 is a counter-regulatory phosphaturic hormone for vitamin D. J Am Soc Nephrol 17:1305–1315CrossRefPubMed Liu S, Tang W, Zhou J et al (2006) Fibroblast growth factor 23 is a counter-regulatory phosphaturic hormone for vitamin D. J Am Soc Nephrol 17:1305–1315CrossRefPubMed
50.
Zurück zum Zitat Cappola AR, Xue QL, Ferrucci L, Guralnik JM, Volpato S, Fried LP (2003) Insulin-like growth factor I and interleukin-6 contribute synergistically to disability and mortality in older women. J Clin Endocrinol Metab 88:2019–2025CrossRefPubMed Cappola AR, Xue QL, Ferrucci L, Guralnik JM, Volpato S, Fried LP (2003) Insulin-like growth factor I and interleukin-6 contribute synergistically to disability and mortality in older women. J Clin Endocrinol Metab 88:2019–2025CrossRefPubMed
51.
Zurück zum Zitat K/DOQI Practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 2003;42(4, S3):S7-S28 K/DOQI Practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 2003;42(4, S3):S7-S28
52.
Zurück zum Zitat Zofkovà I, Kancheva RL, Bendlovà B (1997) Effect of 1,25(OH)2 vitamin D3 on circulating insulin-like growth factor-I and β2 microglobulin in patients with osteoporosis. Calcif Tissue Int 60:236–239CrossRefPubMed Zofkovà I, Kancheva RL, Bendlovà B (1997) Effect of 1,25(OH)2 vitamin D3 on circulating insulin-like growth factor-I and β2 microglobulin in patients with osteoporosis. Calcif Tissue Int 60:236–239CrossRefPubMed
53.
Zurück zum Zitat Jorde R, Waterloo K, Saleh F, Haug E, Svartberg J (2006) Neuropsychological function in relation to serum parathyroid hormone and serum 25-hydroxyvitamin D levels. The Tromso study. J Neurol 253(4):464–470CrossRefPubMed Jorde R, Waterloo K, Saleh F, Haug E, Svartberg J (2006) Neuropsychological function in relation to serum parathyroid hormone and serum 25-hydroxyvitamin D levels. The Tromso study. J Neurol 253(4):464–470CrossRefPubMed
54.
Zurück zum Zitat Miya K, Morimoto S, Fukuo K, Imanaka S, Shiraishi T, Yamamato H, Kitano S, Miyashita Y, Inoue T (1991) Hirotani J. Nippon Ronen Igakkai Zasshi 28(1):34–39PubMed Miya K, Morimoto S, Fukuo K, Imanaka S, Shiraishi T, Yamamato H, Kitano S, Miyashita Y, Inoue T (1991) Hirotani J. Nippon Ronen Igakkai Zasshi 28(1):34–39PubMed
55.
Zurück zum Zitat Przybelski RJ, Binkley NC (2007) Is vitamin D important for preserving cognition? A positive correlation of serum 25-hydroxyvitamin D concentration with cognitive function. Arch Biochem Biophys 460(2):202–205CrossRefPubMed Przybelski RJ, Binkley NC (2007) Is vitamin D important for preserving cognition? A positive correlation of serum 25-hydroxyvitamin D concentration with cognitive function. Arch Biochem Biophys 460(2):202–205CrossRefPubMed
56.
Zurück zum Zitat Burne TH, McGrath JJ, Eyles DW, Mackay-Sim A (2005) Behavioural characterization of vitamin D receptor knockout mice. Behav Brain Res 157(2):299–308CrossRefPubMed Burne TH, McGrath JJ, Eyles DW, Mackay-Sim A (2005) Behavioural characterization of vitamin D receptor knockout mice. Behav Brain Res 157(2):299–308CrossRefPubMed
57.
Zurück zum Zitat Wiese RJ, Uhland-Smith A, Ross TK, Prahl JM, DeLuca HF (1992) Up-regulation of the vitamin D receptor in response to 1,25-dihydroxyvitamin D3 results from ligand-induced stabilization. J Biol Chem 267:20082–20086PubMed Wiese RJ, Uhland-Smith A, Ross TK, Prahl JM, DeLuca HF (1992) Up-regulation of the vitamin D receptor in response to 1,25-dihydroxyvitamin D3 results from ligand-induced stabilization. J Biol Chem 267:20082–20086PubMed
58.
Zurück zum Zitat Francis RM, Peacock M, Barkworth SA (1984) Renal impairment and its effects on calcium metabolism in elderly women. Age Ageing 13:14–20CrossRefPubMed Francis RM, Peacock M, Barkworth SA (1984) Renal impairment and its effects on calcium metabolism in elderly women. Age Ageing 13:14–20CrossRefPubMed
59.
Zurück zum Zitat Nguyen TV, Eisman JA, Kelly PJ, Sambrook PN (1996) Risk factors for osteoporotic fractures in elderly men. Am J Epidemiol 144:255–263PubMed Nguyen TV, Eisman JA, Kelly PJ, Sambrook PN (1996) Risk factors for osteoporotic fractures in elderly men. Am J Epidemiol 144:255–263PubMed
Metadaten
Titel
Independent from muscle power and balance performance, a creatinine clearance below 65 ml/min is a significant and independent risk factor for falls and fall-related fractures in elderly men and women diagnosed with osteoporosis
verfasst von
L. Dukas
E. Schacht
M. Runge
Publikationsdatum
01.07.2010
Verlag
Springer-Verlag
Erschienen in
Osteoporosis International / Ausgabe 7/2010
Print ISSN: 0937-941X
Elektronische ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-009-1064-1

Weitere Artikel der Ausgabe 7/2010

Osteoporosis International 7/2010 Zur Ausgabe

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.